Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer's disease.
Steeland S, Gorlé N, Vandendriessche C, Balusu S, Brkic M, Van Cauwenberghe C, Van Imschoot G, Van Wonterghem E, De Rycke R, Kremer A, Lippens S, Stopa E, Johanson CE, Libert C, Vandenbroucke RE.
Steeland S, et al. Among authors: van cauwenberghe c, van imschoot g, van wonterghem e.
EMBO Mol Med. 2018 Apr;10(4):e8300. doi: 10.15252/emmm.201708300.
EMBO Mol Med. 2018.
PMID: 29472246
Free PMC article.